Evidence map›Paper›PMID 42285920›Full record

ArticleCell death discovery2026

GPR84 aggravates lung inflammation through activating ZBP1-PANoptosome mediated PANoptosis following IAV infection.

Hui Jiang, Youqin Zeng, Shijun Xu, Pengfei Wang, Shengjie You, Xiaobo Zhang, Hao Zhou

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui Jiang *School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Youqin Zeng *College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Shijun XuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID http://orcid.org/0000-0002-7454-0873
Pengfei WangSchool of Life Sciences, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-2454-7652
Shengjie YouChongqing Taiji Industry (Group) Co., Ltd., Chongqing, China.
Xiaobo ZhangSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Hao ZhouSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China. haozhou@cdutcm.edu.cn.ORCID http://orcid.org/0000-0002-0092-7987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza virus-induced pneumonia (IVP) is a contagious lung disease marked by severe lung inflammation following viral infection and remains a significant public health concern due to its high mortality rate. G protein-coupled receptor 84 (GPR84) has been implicated in various inflammatory diseases, however, its role in influenza virus-induced lung inflammation remains poorly understood. In this study, using high-throughput screening, we found that Influenza A virus (IAV) infection markedly upregulates the expression of several G protein-coupled receptors, with GPR84 mRNA and protein levels being highly induced in the lungs of animal models during pneumonia. Mechanistically, GPR84 enhances ZBP1-PANoptosome mediated PANoptosis and exacerbates the release of inflammatory chemokines and danger associated molecular patterns (DAMPs). Notably, deletion of GPR84 attenuates influenza virus-induced PANoptosis, indicating that GPR84 participates in regulating lung inflammation and the pathogenesis of pneumonia during influenza infection. Overall, these findings demonstrate that GPR84 plays a central role in influenza virus-induced lung inflammation by promoting PANoptosis and the release of inflammatory mediators. Targeting GPR84 attenuates IAV-induced PANoptosis, highlighting its potential as a therapeutic target to mitigate the pathogenesis of influenza virus-induced pneumonia.

Identifiers

PMID42285920
PMCPMC13486761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.